Eli Lilly & Co.’s Alzheimer’s disease drug Kisunla failed to get the backing of European regulators, who said its benefits don’t outweigh the risk of potentially fatal bleeding in the brain.

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

The Chicago Sun-Times Editorial Board has ceased to exist after 75 years, with the paper now focusing on publishing letters ...

They put relievers Tyson Miller (left hip impingement, retroactive to March 21) and Ryan Brasier (strained left groin, ...

A Myrtle Beach area business has expanded, opening what is believed to be the first bookstore and wine bar along the Grand ...

For the second year in a row, Boston College has clinched the top overall seed in the NCAA tournament. That was decided even ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/ ...

Eli Lilly's global CEO David Ricks is spearheading the worldwide launch of popular diabetes and anti-obesity drugs Mounjaro and Zepbound. On a visit to India, the chief of the $45-billion ...

It’s not just for the celebrities anymore. The ‘miracle’ weight loss drug race has arrived in India with the launch of American drugmaker Eli Lilly’s Mounjaro last week. Priced at ...

Eli Brand joined the WSOC team in April of 2024 as a reporter. Eli is a North Carolina native and was born in Charlotte. He grew up in Shelby where he graduated from Crest High School, before ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best ...